Abound Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $284K | Buy |
1,531
+4
| +0.3% | +$743 | 0.08% | 56 |
|
2025
Q1 | $320K | Buy |
1,527
+136
| +10% | +$28.5K | 0.11% | 51 |
|
2024
Q4 | $247K | Sell |
1,391
-105
| -7% | -$18.7K | 0.08% | 59 |
|
2024
Q3 | $295K | Hold |
1,496
| – | – | 0.1% | 48 |
|
2024
Q2 | $257K | Buy |
1,496
+179
| +14% | +$30.7K | 0.09% | 48 |
|
2024
Q1 | $240K | Sell |
1,317
-197
| -13% | -$35.9K | 0.09% | 52 |
|
2023
Q4 | $235K | Buy |
1,514
+122
| +9% | +$18.9K | 0.09% | 50 |
|
2023
Q3 | $207K | Hold |
1,392
| – | – | 0.09% | 51 |
|
2023
Q2 | $188K | Buy |
1,392
+191
| +16% | +$25.7K | 0.08% | 55 |
|
2023
Q1 | $191K | Buy |
1,201
+145
| +14% | +$23.1K | 0.09% | 53 |
|
2022
Q4 | $171K | Buy |
1,056
+121
| +13% | +$19.6K | 0.08% | 53 |
|
2022
Q3 | $126K | Buy |
+935
| New | +$126K | 0.07% | 53 |
|